Literature DB >> 11231481

Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.

K Yamashita1, T Yoshida, H Shinoda, I Okayasu.   

Abstract

BACKGROUND AND
OBJECTIVE: Abnormal protein expression and gene mutation should be examined on exactly identified lesions. To perform simultaneous analyses of oncogene or tumor suppressor gene mutations and related protein expression in single histologic sections, we have developed a novel method using an antigen-retrieval solution for a polymerase chain reaction template before immunohistochemical staining.
METHODS: Using 20 cases of sporadic colorectal carcinoma, several kinds of antigen-retrieval solutions were tested after heating rehydrated, 4-microm-thick, formalin-fixed, paraffin-embedded histologic sections at 96 degrees C for 20 minutes. Polymerase chain reaction-single-strand conformation polymorphism analysis was conducted for p53 (exons 5 through 9) and K-ras (exons 1 and 2), and the histologic sections were then immunostained with monoclonal antibody against p53.
RESULTS: DNA analysis of antigen-retrieval solutions was possible in all 20 cases and revealed completely consistent results (100%) with fresh cancer tissue and microdissected cancer tissue of paraffin-embedded histologic sections. With this method, K-ras mutations were positive in 10 of 20 cases (exon 1 in 9 cases and exon 2 in 1 case) and p53 mutations were positive in 9 of 20 cases (exon 5 in 4 cases, exon 6 in 1, exon 7 in 3, and exon 8 in 1 case), with 8 of the 9 p53 mutation cases showing diffuse p53 protein expression on immunostaining. Base alterations of all abnormal conformers were confirmed with direct sequencing. For polymerase chain reaction-single-strand conformation polymorphism analysis, sodium citrate buffer (pH 6.0) was found to be the optimal antigen-retrieval solution.
CONCLUSIONS: This newly developed method can be used for routine immunostaining and genetic analysis with single histologic sections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231481     DOI: 10.5858/2001-125-0347-NMFSAO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Missense and nonsense mutations of p53 gene in patients with colorectal adenocarcinoma in isfahan, central iran.

Authors:  R Golmohammadi; M J Namazi; M Nikbakht; M Salehi
Journal:  Iran Red Crescent Med J       Date:  2011-03-01       Impact factor: 0.611

2.  Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.

Authors:  T Yoshida; N Matsumoto; T Mikami; I Okayasu
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

3.  Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran.

Authors:  Rahim Golmohammadi; Mohammad J Namazi; Mehdi Nikbakht; Mohammad Salehi; Mohammad H Derakhshan
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

4.  Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma.

Authors:  N Matsumoto; T Yoshida; K Yamashita; Y Numata; I Okayasu
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

5.  Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.

Authors:  Mina Waraya; Keishi Yamashita; Akira Ema; Natsuya Katada; Shiro Kikuchi; Masahiko Watanabe
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.